Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 8/20 | 0.33 |
| ▸ | PDCD1 | Q15116 | 2/20 | 0.32 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | NPR3 | P17342 | 1/20 | 0.30 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7356318 | 0.80 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1POLBTHRBPDCD1 | |
| SCHEMBL5504851 | 0.75 | TSHR (0.39) | SMN1; SMN2ALDH1A1POLBTHRBTSHR | |
| SCHEMBL7361998 | 0.74 | TSHR (0.38) | SMN1; SMN2ALDH1A1POLBTHRBTSHR | |
| SCHEMBL7364312 | 0.67 | ALDH1A1 (0.35) | SMN1; SMN2ALDH1A1POLBTHRBTSHR | |
| SCHEMBL28507628 | 0.67 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1POLBTHRBTSHR | |
| SCHEMBL13238482 | 0.65 | DRD2 (0.47) | ALDH1A1THRBKMT2A | |
| SCHEMBL5549908 | 0.63 | SMN1; SMN2 (0.39) | SMN1; SMN2ALDH1A1POLBTHRBPDCD1 | |
| SCHEMBL8501813 | 0.63 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1POLBPDCD1CD274 | |
| SCHEMBL8499683 | 0.63 | L3MBTL1 (0.39) | SMN1; SMN2ALDH1A1THRB | |
| SCHEMBL8276616 | 0.63 | TOP2A (0.39) | SMN1; SMN2THRBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1051176-A4 | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS | AVENTIS PHARM PROD INC (US) | 2002-06-12 | — | — | EP | disclosed |
| EP-1051176-A1 | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS | Aventis Pharmaceuticals Products Inc. (US) | 2000-11-15 | — | — | EP | disclosed |
| WO-2000032590-A1 | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-1999037304-A1 | SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS | AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) | 1999-07-29 | — | — | WO | disclosed |